Details
- Autor(en) / Beteiligte
- Titel
- Feasibility of PEG-rhG-CSF in the first-line treatment of diffuse large B-cell lymphoma receiving dose-adjusted EPOCH plus rituximab
- Ist Teil von
- Zhōnghuá xuèyèxué zázhì, 2020-02, Vol.41 (2), p.167-170
- Ort / Verlag
- China
- Erscheinungsjahr
- 2020
- Quelle
- MEDLINE
- Sprache
- Chinesisch
- Identifikatoren
- ISSN: 0253-2727DOI: 10.3760/cma.j.issn.0253-2727.2020.02.016Titel-ID: cdi_proquest_miscellaneous_2374352907
- Format
- –
- Schlagworte
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Cyclophosphamide, Doxorubicin, Etoposide, Feasibility Studies, Granulocyte Colony-Stimulating Factor, Humans, Lymphoma, Large B-Cell, Diffuse - drug therapy, Polyethylene Glycols, Prednisone, Recombinant Proteins, Rituximab, Vincristine